Estonian Health Insurance Fund announces procurement for purchase of vaccines

TALLINN – The Estonian Health Insurance Fund has announced a public procurement for the purchase of tuberculin as well as tuberculosis, rabies and complex vaccines.

In particular, the Health Insurance Fund wants to purchase 50,000 doses of vaccine containing live attenuated tuberculosis bacteria for the active immunization of newborns against tuberculosis, in injectable form, it appears from the procurement documents.

In addition, 1,000 doses of the diphtheria, tetanus, pertussis, inactivated poliomyelitis + Hemophilus Influenzae type b combination vaccine for the active immunization of children in a single dose in a pre-filled syringe or one dose in one vial.

The Health Insurance Fund also wants to purchase 1,000 doses of inactivated whole-virion rabies vaccine for single-dose administration, 100 doses of Haemophilus influenzae type b vaccine for active immunization of children with a single dose, and 1,050 doses of tuberculin in injectable form.

The public procurement is divided into five parts and the tenderer may submit a tender to one or more parts. The Health Insurance Fund wants to enter into a procurement contract from Nov. 1 this year until Jan. 31, 2024. Tenders can be submitted until the morning of Oct. 11.